Research PaperJournal of Pharmacology and PharmacotherapeuticsVol. 12 | Issue 4 | 2022 | pp. 163–167Open access
Comparison of Serum 25-Hydroxyvitamin D Levels After A Single Oral Dose of Vitamin D3 Formulations in Mild Vitamin D3 Deficiency
- 1,
- 2,
- 3,
- 4,
- 5,
- 6,
- 5*
- 1 Department of Pharmacognosy, M. M. College of Pharmacy, M.M. (Deemed to be University), Ambala, India.
- 2 Department of Pharmacology J K Institute of Pharmacy and Management College, Bulandshahr, India.
- 3 Department of Pharmacology, IIMT College of Pharmacy, Greater Noida, Uttar Pradesh, India.
- 4 Department of Physical Medicine and Rehabilitation, AIIMS, Patna, Bihar, India.
- 5 Department of Neurosurgery, ABVIMS, Dr RML Hospital, New Delhi, India.
- 6 Department of Pharmacutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar, Haryana, India.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Ashok Kumar
Department of Neurosurgery, ABVIMS, Dr RML Hospital, New Delhi, India.
Email: ashujinagal12@gmail.com
Copyright: © 2022 Manuscript Technomedia LLP. This is an open access article.
- Published:
- Feb 9, 2022
- Received:
- Aug 13, 2021
- Accepted:
- Oct 20, 2021
How to cite
Munjal, K., Sharma, S., Sharma, S., Kumar, D., Choudhary, A., Berwal, R., & Kumar, A. (2022). Comparison of Serum 25-Hydroxyvitamin D Levels After A Single Oral Dose of Vitamin D3 Formulations in Mild Vitamin D3 Deficiency. Journal of Pharmacology and Pharmacotherapeutics, 12(4), 163–167. https://doi.org/10.4103/jpp.jpp_105_21
Abstract
Objective: To compare the levels of serum 25 Hydroxyvitamin D levels after a single large oral dose (60,000 IU) of different vitamin D3 formulations. Materials and Methods: Ninety-one volunteers with mild vitamin D deficiency (18–29 ng/ml) were selected and randomly assigned to three parallel groups. Groups-I received liquid, Group-II received sachet, and Group-III received tablet formulation of cholecalciferol as a single dose of 60,000 IU orally after 8–10 h of overnight fasting. Serum 25(OH) D concentrations were measured at baseline, 24 h, 7 days, and 14 days after drug administration. Various hematology and biochemical parameters were also assessed for baseline safety evaluation. Results: Baseline serum 25(OH) D concentrations in Groups I (liquid), II (sachet), and III (tablet) was 24.75 ± 4.77 ng/mL, 23.25 ± 4.15 ng/mL, and 23.18 ± 5.52 ng/mL, respectively. After supplemented with three formulations, only tablet group after 24 h showed increase in serum 25-OH-D concentration of 8.07 units from its baseline. Whereas after 7th day, no significant difference in absorption was observed but after 14th day, all three groups showed increase in serum 25-OH-D concentration, in which tablet group (50.10 ± 94.99 ng/ml) showed highest increase in absorption (26.92 units) from their baseline values. During intergroup comparison between three formulations at the time of investigation, only liquid group after 24 h showed increased serum concentration by P values (0.03, 0.02) as compared to sachet and tablet group. However, After 7th and 14th day, there was no statistically difference was observed between three groups. Conclusion: Single oral dose of 60,000 IU dose of vitamin D liquid formulation has higher absorption value as after 24 h and tablet formulation showed higher absorption after 7th days. In emergency paucity of vitamin D, these observations findings can have critical conclusions to state the suitable dietary formulation of vitamin D.
Keywords
Subject
Article metadata
| Title | Comparison of Serum 25-Hydroxyvitamin D Levels After A Single Oral Dose of Vitamin D3 Formulations in Mild Vitamin D3 Deficiency |
|---|---|
| Authors | Kavita Munjal; Sonika Sharma; Shallu Sharma; Deepak Kumar; Ajay Choudhary; Ravi Berwal; Ashok Kumar |
| Affiliations | Department of Pharmacognosy, M. M. College of Pharmacy, M.M. (Deemed to be University), Ambala, India.; Department of Pharmacology J K Institute of Pharmacy and Management College, Bulandshahr, India.; Department of Pharmacology, IIMT College of Pharmacy, Greater Noida, Uttar Pradesh, India.; Department of Physical Medicine and Rehabilitation, AIIMS, Patna, Bihar, India.; Department of Neurosurgery, ABVIMS, Dr RML Hospital, New Delhi, India.; Department of Pharmacutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar, Haryana, India. |
| Corresponding author | ashujinagal12@gmail.com |
| Journal | Journal of Pharmacology and Pharmacotherapeutics |
| Volume / Issue | Vol. 12, Issue 4 (2022) |
Also in this issue
- Mucormycosis – The black menace in COVID-19pp. 151–156
- Oliceridine - Breakthrough in the Management of Painpp. 157–162
- Impact of Clinical Pharmacist Interventions in Resolving Drug-Related Problems in Patients with Systemic Autoimmune Disorderspp. 168–171
- Monitoring Adverse Drug Reactions and Incidence of Potential Statin-Drug Interactionspp. 172–174
- Ceftriaxone-Induced Thrombocytopenia in a Patient with Bacterial Meningoencephalitispp. 175–176
Readers Also Viewed
Development and Validation of UV/visible Spectrophotometric Method for Estimation of Piroxicam from Bulk and Formulation
Sandip Mohan Honmane, Kunal Rajaram Yadav, Yuvraj Dilip Dange
Apr 23, 2025
Effects of Artificial Intelligence on Academic Performance of Library and Information Science University Students: A Meta-Analysis (2023-2025)
Kayode Sunday John Dada
Aug 6, 2026
Bridging Innovation and Impact: A Multidisciplinary Approach to Contemporary Research Challenges
Mueen Ahmed KK
Aug 11, 2026